Senti Biosciences Holdings Inc (SNTI) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Senti Biosciences Holdings Inc   (NASDAQ: SNTI)


Senti Biosciences Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Senti Biosciences Holdings Inc's ROI in the second quarter of 2026?
Senti Biosciences Holdings Inc recorded a cumulative net loss of $-50 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -166.29%.

Within the Healthcare sector 206 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3491 to 4049.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -54.83 % -43.36 % -31.36 % -13.49 % -28.44 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 17 24 37 41 59
Return On Investment (TTM) -166.29 % -128.52 % -117.86 % -74.36 % -88.38 %
SNTI's Overall Ranking # 4049 # 3491 # 3595 # 3476 # 3608
Seq. Investment Change TTM -25.69 % -23.06 % -18.54 % -3.03 % -6.81 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -50 -52 -61 -48 -58




Return On Investment SNTI's Ranking
Within: No.
Industry # 24
Sector # 207
Overall # 4049

Return On Investment Statistics
High Average Low
-2.23 %
-4256.17 %
-83956.1 %
(Dec 31 2021)   (Mar 31 2021)







Financial Statements
Senti Biosciences Holdings Inc's II. Quarter Investments $ 17 Millions SNTI's Balance sheet
Senti Biosciences Holdings Inc's II. Quarter Income $ -13 Millions Quarterly SNTI's Income Statement
SNTI's Income by Division See SNTI's Income by Division


SNTI Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 37 60 77 163 228
Y / Y Investment Growth -37.51 % -22.38 % -52.81 % -28.68 % -
Net Income in Millions -61 -53 -71 -58 -4
Y / Y Net Income Growth - - - - -
Annual Return On Investment -164.94 % -88.56 % -92.52 % -35.77 % -1.69 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SNTI's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SNTI's Competitors
Subscribers only: Roi for Senti Biosciences Holdings Inc's Suppliers
Subscribers only: Return On Investment for SNTI's Customers

Other Ratios
SNTI's Roa SNTI's Inventory Turnover Ratio SNTI's Growth Rates SNTI's Dividend Statistics
SNTI's Profitability Ratios SNTI's Asset Turnover Ratio SNTI's Dividend Growth
SNTI's Roe SNTI's Valuation Ratios SNTI's Financial Strength Ratios SNTI's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-08T22:23:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.